A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
Clinical trial NCT06425341 · RECRUITING
Trial details
- NCT number
- NCT06425341
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-06
- Primary completion
- 2026-08-30
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.